姚凡, 董明, 金锋, 路平, 陈波, 王舒宝. 胰液中CLDN5和NPTX2基因高甲基化在胰腺癌诊断中的意义[J]. 中国肿瘤临床, 2007, 34(17): 970-972,981.
引用本文: 姚凡, 董明, 金锋, 路平, 陈波, 王舒宝. 胰液中CLDN5和NPTX2基因高甲基化在胰腺癌诊断中的意义[J]. 中国肿瘤临床, 2007, 34(17): 970-972,981.
Yao Fan, Dong Ming, Jin Feng, Lu Ping, Chen Bo, Wang Shubao. Hypermethylation of CLDN5 and NPTX2 Genes in Pancreatic Juice:Potential Diagnostic Significance in Human Pancreatic Cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 34(17): 970-972,981.
Citation: Yao Fan, Dong Ming, Jin Feng, Lu Ping, Chen Bo, Wang Shubao. Hypermethylation of CLDN5 and NPTX2 Genes in Pancreatic Juice:Potential Diagnostic Significance in Human Pancreatic Cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 34(17): 970-972,981.

胰液中CLDN5和NPTX2基因高甲基化在胰腺癌诊断中的意义

Hypermethylation of CLDN5 and NPTX2 Genes in Pancreatic Juice:Potential Diagnostic Significance in Human Pancreatic Cancer

  • 摘要: 目的 :探讨胰腺癌和慢性胰腺炎患者胰液中CLDN5和NPTX2基因高甲基化在胰腺癌诊断中的临床意义。 方法 :MSP方法检测21例胰腺癌和8例慢性胰腺炎患者胰液中CLDN5和NPTX2基因启动子区CpG岛高甲基化。 结果 :21例胰腺癌患者的胰液中,17例(81.0%)CLDN5基因高甲基化阳性;15例(71.4%)NPTX2基因高甲基化阳性。8例慢性胰腺炎患者的胰液中,各有1例(12.5%)CLDN5和NPTX2基因高甲基化阳性。 结论 :CLDN5和NPTX2基因高甲基化作为分子生物学标志物可用于胰腺癌的诊断,有较高的临床应用价值。

     

    Abstract: Objective :To investigate hypermethylation of claudin5 (CLDN5) and neuronal pen-traxin Ⅱ(NPTX2) in pure pancreatic juice(PPJ) endoscopically aspirated from patients with pancreaticcancer(PCa) and chronic pancreatitis (CP),and to evaluate their clinical significance in diagnosing hu-man pancreatic cancer. Methods :Methylation-specific polymerase chain reaction (MSP) was used to de-tect hypermethylation of CLDN5 and NPTX2 in PPJ from 21 patients with PCa and 8 patients with CP. Results : Hypermethylation of CLDN5 was found in 81.0%(17/21) and hypermethylation of NPTX2 wasfound in 71.4%(15/21) of PPJ samples from patients with PCa. In patients with CP, 12.5%(1/8) showedhypermethylation of either of the 2 genes. Hypermethylation of NPTX2 and CLDN5 was significantlydifferent between PCa and CP (P<0.05). Conclusion :Hypermethylation of NPTX2 and CLDN5 mightbe a molecular marker to distinguish between malignant and benign disease of the pancreas.

     

/

返回文章
返回